Status:
UNKNOWN
Vasoactive Peptides in Portal Pressure
Lead Sponsor:
Bayside Health
Conditions:
Portal Hypertension
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study is looking at the detection of vasoactive peptides in portal hypertension.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- HVPG \>= 12 mmHg
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00163982
Last Update
July 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3181